RHUMBLINE ADVISERS - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$139,243
-12.6%
135,202
-1.6%
0.00%
Q2 2023$159,404
+77280.6%
137,418
+0.7%
0.00%
Q1 2023$206
-38.0%
136,445
+2.7%
0.00%
Q4 2022$332
-99.9%
132,887
+2.8%
0.00%
-100.0%
Q3 2022$545,000
+61.7%
129,259
+7.0%
0.00%
Q2 2022$337,000
-41.8%
120,787
+19.3%
0.00%
-100.0%
Q1 2022$579,000
-38.5%
101,284
-1.8%
0.00%0.0%
Q4 2021$941,000
-16.2%
103,098
-1.8%
0.00%
-50.0%
Q3 2021$1,123,000
-28.2%
105,039
+4.2%
0.00%0.0%
Q2 2021$1,565,000
-7.9%
100,829
-3.9%
0.00%0.0%
Q1 2021$1,700,000
-30.2%
104,876
-8.8%
0.00%
-33.3%
Q4 2020$2,435,000
+43.1%
115,038
+0.2%
0.00%0.0%
Q3 2020$1,702,000
-14.2%
114,862
-14.8%
0.00%0.0%
Q2 2020$1,983,000
+43.5%
134,826
+14.5%
0.00%0.0%
Q1 2020$1,382,000
-48.1%
117,716
+4.0%
0.00%
-25.0%
Q4 2019$2,661,000
+42.7%
113,227
+12.3%
0.00%
+33.3%
Q3 2019$1,865,000
+0.6%
100,802
+1.1%
0.00%0.0%
Q2 2019$1,853,000
-14.4%
99,678
+12.5%
0.00%
-25.0%
Q1 2019$2,165,000
-6.8%
88,585
-1.1%
0.00%
-20.0%
Q4 2018$2,323,000
+24.8%
89,541
+52.2%
0.01%
+25.0%
Q3 2018$1,862,000
-19.3%
58,829
-1.0%
0.00%
-20.0%
Q2 2018$2,308,000
+69.8%
59,401
+20.7%
0.01%
+66.7%
Q1 2018$1,359,000
+74.9%
49,228
+14.7%
0.00%
+50.0%
Q4 2017$777,000
-5.9%
42,906
-16.1%
0.00%0.0%
Q3 2017$826,000
+17.8%
51,120
+1.0%
0.00%0.0%
Q2 2017$701,000
+5.3%
50,630
+14.1%
0.00%0.0%
Q1 2017$666,000
+47.0%
44,381
+28.3%
0.00%
+100.0%
Q4 2016$453,000
-25.9%
34,603
-2.4%
0.00%
-50.0%
Q3 2016$611,000
-3.8%
35,466
+0.8%
0.00%0.0%
Q2 2016$635,000
+14.8%
35,201
+20.8%
0.00%0.0%
Q1 2016$553,000
-28.7%
29,134
+0.3%
0.00%0.0%
Q4 2015$776,000
+20.9%
29,054
+10.4%
0.00%0.0%
Q3 2015$642,000
-4.6%
26,319
+21.9%
0.00%0.0%
Q2 2015$673,000
+116.4%
21,585
+1.1%
0.00%
+100.0%
Q1 2015$311,000
+88.5%
21,350
+29.8%
0.00%
Q4 2014$165,000
+25.0%
16,450
+3.6%
0.00%
Q3 2014$132,000
-23.3%
15,875
+13.8%
0.00%
-100.0%
Q2 2014$172,00013,9500.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders